Jonas is a partner at Alder and has extensive experience as a business leader. He is responsible for the portfolio company Umia and previously responsible for the divested companies r2p and Jernforsen. Jonas is also responsible for the Danish market together with Knud Andersen. Prior to Alder , Jonas was CEO of SLS Venture, the second largest biotech fund in the Nordic region. Prior to that, he was CEO of Medivir, which during Jonas' tenure was listed and developed into an international research company.
For almost 15 years, Jonas worked for the Pharmacia Group, where he built up business, R&D and manufacturing organisations in the Nordics, Japan and Italy. He left in 1995 as Vice President of the pharmaceutical division (Pharmacia Therapeutics AB). In addition, Jonas has worked as a consultant at Indevo, a consulting company focusing on business and organisational development and turn around management.
Jonas has extensive experience from board work in Europe and North America.
Board assignments at Alder: Umia, AB Inventech